Table 1.
Cancer Type | EGFR expression | HER-2 expression | Approved Targeted Therapy |
---|---|---|---|
Breast Cancer | Yes | Yes | Lapatinib, trastuzumab, pertuzumab, T-DM1 |
Colorectal Cancer | Yes | Yes | Cetuximab, panitumumab |
Gastric Cancer (GEJ) | No | Yes | Trastuzumab |
HNSCC | Yes | No | Cetuximab |
NSCLC | Yes | No | Afatinib, Erlotinib, Gefitinib |
Pancreatic Cancer | Yes | Yes | Erlotinib |